In this work, the antibacterial activity of deflazacort and several of its synthetic precursors\nwas tested against a panel of bacterial pathogens responsible for most drug-resistant infections\nincluding Staphylococcus aureus, Enterococcus spp., Acinetobacter baumannii, Pseudomonas aeruginosa,\nKlebsiella pneumoniae, Escherichia coli, and Enterobacter spp. The derivative of deflazacort, PYED-1..................
Loading....